TB-500 is a synthetic fragment of the naturally occurring protein Thymosin Beta-4, prescribed to support cellular repair, flexibility, and full-body recovery. Frequently paired with BPC-157 for a comprehensive regenerative protocol.
Goldstein et al., Expert Opinion on Biological Therapy, 2012
Comprehensive review of TB-4 across cardiac, dermal, corneal, and CNS repair models — consistent evidence of accelerated tissue regeneration and reduced fibrosis.
Sosne et al., Annals of the New York Academy of Sciences, 2015
Phase II human trials demonstrated statistically significant improvement in dry eye symptoms and corneal epithelial healing versus placebo.
Bock-Marquette et al., Nature, 2004
Landmark study showing TB-4 preserves cardiomyocytes and stimulates coronary vessel growth after myocardial infarction in animal models.
Physician-supervised subcutaneous injection protocol, typically 4–6 weeks loading with a lower maintenance phase. Custom dosing based on your clinical goals.
BPC-157 is highly localized in its tissue-repair action; TB-500 works more systemically via cell migration and angiogenesis. They are complementary and often prescribed together.
A typical loading phase is 4–6 weeks with a lower-dose maintenance phase thereafter, based on your clinical response.
Only with clearance from your surgeon. We coordinate with your surgical team before starting any post-operative regenerative protocol.
BPC-157 is a synthetic peptide derived from a naturally occurring protein in gastric juice, prescribed under our physician oversight to support…
$110 → PeptideMOTs-C is a mitochondrial-derived peptide that plays a central role in metabolic regulation, insulin sensitivity, and cellular energy. It is…
$100 → GLP-1Our GLP-1 program combines compounded Semaglutide or Tirzepatide with clinical oversight, nutrition guidance, and body composition tracking. Weight…
$100 →Every protocol is prescribed and monitored by our clinical team.
